What's in Universitair Ziekenhuis Brussel's pipeline?

Universitair Ziekenhuis Brussel has 8 drugs in our index: 5 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Universitair Ziekenhuis Brussel's portfolio?

Top competitors by shared drug class: Armata Pharmaceuticals, Inc., Başakşehir Çam & Sakura City Hospital, Bozyaka Training and Research Hospital, Bursa City Hospital, Centre of Postgraduate Medical Education.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universitair-ziekenhuis-brussel.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Universitair Ziekenhuis Brussel — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universitair Ziekenhuis Brussel pipeline: 5 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 1 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
300IU rec-LH	300IU rec-LH	marketed
progesterone 600mg	progesterone 600mg	marketed
Absence of epidural analgesia	Absence of epidural analgesia	marketed
Epidural analgesia Ropivacaine	Epidural analgesia Ropivacaine	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels	Anesthesia/Pain Management
glucose 20%	glucose 20%	marketed	Carbohydrate supplement; hypertonic dextrose solution		Endocrinology; Critical Care; Supportive Care
Taurolidine Urokinase	Taurolidine Urokinase	phase 3	Antimicrobial		Infectious Diseases

Therapeutic area mix

Anesthesia/Pain Management · 1
Endocrinology; Critical Care; Supportive Care · 1
Infectious Diseases · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Armata Pharmaceuticals, Inc. · 1 shared drug class
Başakşehir Çam & Sakura City Hospital · 1 shared drug class
Bozyaka Training and Research Hospital · 1 shared drug class
Bursa City Hospital · 1 shared drug class
Centre of Postgraduate Medical Education · 1 shared drug class
Clinique Saint-Jean, Bruxelles · 1 shared drug class
Complejo Hospitalario Universitario de Granada · 1 shared drug class
Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universitair Ziekenhuis Brussel:

Cite this brief

Drug Landscape (2026). Universitair Ziekenhuis Brussel — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universitair-ziekenhuis-brussel. Accessed 2026-05-18.